For patients with a displaced hip fracture, hemiarthroplasty or total hip replacement is the recommended treatment. In this case, the patient has a confirmed intracapsular fracture of the neck of femur, which carries a high risk of avascular necrosis. Hemiarthroplasty or total hip replacement is preferred for patients over 70 years old, with hemiarthroplasty being the better option for those with serious comorbidities, dementia, or immobility. Therefore, the patient should be managed with a hemiarthroplasty. The use of a dynamic hip screw, internal fixation, or Intramedullary nail is not appropriate for this type of fracture.

Hip fractures are a common occurrence, particularly in elderly women with osteoporosis. The femoral head’s blood supply runs up the neck, making avascular necrosis a potential risk in displaced fractures. Symptoms of a hip fracture include pain and a shortened and externally rotated leg. Patients with non-displaced or incomplete neck of femur fractures may still be able to bear weight. Hip fractures can be classified as intracapsular or extracapsular, with the Garden system being a commonly used classification system. Blood supply disruption is most common in Types III and IV fractures.

Intracapsular hip fractures can be treated with internal fixation or hemiarthroplasty if the patient is unfit. Displaced fractures are recommended for replacement arthroplasty, such as total hip replacement or hemiarthroplasty, according to NICE guidelines. Total hip replacement is preferred over hemiarthroplasty if the patient was able to walk independently outdoors with the use of a stick, is not cognitively impaired, and is medically fit for anesthesia and the procedure. Extracapsular hip fractures can be managed with a dynamic hip screw for stable intertrochanteric fractures or an intramedullary device for reverse oblique, transverse, or subtrochanteric fractures.

Pregnant women with rheumatoid arthritis can safely use hydroxychloroquine, but must stop taking methotrexate at least 6 months before attempting to conceive. It is incorrect to continue taking both medications, and there is no need to increase folic acid intake for rheumatoid arthritis or hydroxychloroquine use during pregnancy. It is also worth noting that some women with rheumatoid arthritis may experience symptom relief or remission during pregnancy.

Hydroxychloroquine: Uses and Adverse Effects

Hydroxychloroquine is a medication commonly used in the treatment of rheumatoid arthritis and systemic/discoid lupus erythematosus. It is similar to chloroquine, which is used to treat certain types of malaria. However, hydroxychloroquine has been found to cause bull’s eye retinopathy, which can result in severe and permanent visual loss. Recent data suggests that this adverse effect is more common than previously thought, and the most recent guidelines recommend baseline ophthalmological examination and annual screening, including colour retinal photography and spectral domain optical coherence tomography scanning of the macula. Despite this risk, hydroxychloroquine may still be used in pregnant women if needed. Patients taking this medication should be asked about visual symptoms and have their visual acuity monitored annually using a standard reading chart.

Reactive arthritis is linked to dactylitis as a clinical sign.

In the case of a man experiencing joint pain in his lower limbs after a gastrointestinal infection, reactive arthritis is a likely cause. The question is asking for the associated clinical sign, which is dactylitis. This condition is commonly caused by spondyloarthropathies like reactive and psoriatic arthritis. On the other hand, a Z-thumb deformity is related to rheumatoid arthritis, while leukonychia is caused by hypoalbuminemia. Clubbing, on the other hand, can be caused by various factors such as congenital heart defects and different types of cancer.

Understanding Dactylitis: Inflammation of Fingers and Toes

Dactylitis is a medical condition that refers to the inflammation of a digit, which can be a finger or a toe. This condition can be caused by various factors, including spondyloarthritis, which includes reactive and psoriatic arthritis. Other causes of dactylitis include sickle-cell disease, tuberculosis, sarcoidosis, and syphilis, although these are rare.

Dactylitis can cause swelling, pain, and stiffness in the affected digit, which can make it difficult to perform daily activities. Treatment for dactylitis depends on the underlying cause and may include medication, physical therapy, or surgery in severe cases. With proper diagnosis and treatment, most people with dactylitis can manage their symptoms and improve their quality of life.

The presence of sacro-ilitis on a pelvic X-ray is the most supportive factor for diagnosing ankylosing spondylitis.

Investigating and Managing Ankylosing Spondylitis

Ankylosing spondylitis is a type of spondyloarthropathy that is associated with HLA-B27. It is more commonly seen in males aged 20-30 years old. Inflammatory markers such as ESR and CRP are usually elevated, but normal levels do not necessarily rule out ankylosing spondylitis. HLA-B27 is not a reliable diagnostic tool as it can also be positive in normal individuals. The most effective way to diagnose ankylosing spondylitis is through a plain x-ray of the sacroiliac joints. However, if the x-ray is negative but suspicion for AS remains high, an MRI can be obtained to confirm the diagnosis.

Management of ankylosing spondylitis involves regular exercise, such as swimming, and the use of NSAIDs as the first-line treatment. Physiotherapy can also be helpful. Disease-modifying drugs used for rheumatoid arthritis, such as sulphasalazine, are only useful if there is peripheral joint involvement. Anti-TNF therapy, such as etanercept and adalimumab, should be given to patients with persistently high disease activity despite conventional treatments, according to the 2010 EULAR guidelines. Ongoing research is being conducted to determine whether anti-TNF therapies should be used earlier in the course of the disease. Spirometry may show a restrictive defect due to a combination of pulmonary fibrosis, kyphosis, and ankylosis of the costovertebral joints.

The reactivation of TB is a possible side effect of TNF-α inhibitors.

Managing Rheumatoid Arthritis with Disease-Modifying Therapies

The management of rheumatoid arthritis (RA) has significantly improved with the introduction of disease-modifying therapies (DMARDs) in the past decade. Patients with joint inflammation should start a combination of DMARDs as soon as possible, along with analgesia, physiotherapy, and surgery. In 2018, NICE updated their guidelines for RA management, recommending DMARD monotherapy with a short course of bridging prednisolone as the initial step. Monitoring response to treatment is crucial, and NICE suggests using a combination of CRP and disease activity to assess it. Flares of RA are often managed with corticosteroids, while methotrexate is the most widely used DMARD. Other DMARDs include sulfasalazine, leflunomide, and hydroxychloroquine. TNF-inhibitors are indicated for patients with an inadequate response to at least two DMARDs, including methotrexate. Etanercept, infliximab, and adalimumab are some of the TNF-inhibitors available, each with their own risks and administration methods. Rituximab and Abatacept are other DMARDs that can be used, but the latter is not currently recommended by NICE.

A mutation in the fibrillin-1 protein is responsible for causing Marfan’s syndrome. This protein is coded by the Marfan syndrome gene (MSF1) located on chromosome 15. Connective tissue contains fibrillin, which is a glycoprotein. Synovial fluid contains hyaluronic acid, while elastin is an extracellular matrix protein found in connective tissue. Laminin is another extracellular matrix protein that forms part of the basement membrane.

The presence of Heberden’s nodes, which are bony swellings at the DIP joints, is a characteristic feature of osteoarthritis in the hand. Pain that worsens with activity, rather than rest, is also more indicative of OA than inflammatory arthritis. Psoriatic arthritis can cause swelling of the DIP joints, but the swelling is typically boggy rather than bony, and the pain tends to be worse in the morning and improve with activity. Reactive arthritis is unlikely to cause a DIP predominant arthritis, as it typically presents as a large joint lower limb oligoarthritis, and there is no recent history of infection. Rheumatoid arthritis does not typically affect the DIP joints.

Understanding Osteoarthritis of the Hand

Osteoarthritis of the hand, also known as nodal arthritis, is a condition that occurs when the cartilage at synovial joints is lost, leading to the degeneration of underlying bone. It is more common in women, usually presenting after the age of 55, and may have a genetic component. Risk factors include previous joint trauma, obesity, hypermobility, and certain occupations. Interestingly, osteoporosis may actually reduce the risk of developing hand OA.

Symptoms of hand OA include episodic joint pain, stiffness that worsens after periods of inactivity, and the development of painless bony swellings known as Heberden’s and Bouchard’s nodes. These nodes are the result of osteophyte formation and are typically found at the distal and proximal interphalangeal joints, respectively. In severe cases, there may be reduced grip strength and deformity of the carpometacarpal joint of the thumb, resulting in fixed adduction.

Diagnosis is typically made through X-ray, which may show signs of osteophyte formation and joint space narrowing before symptoms develop. While hand OA may not significantly impact a patient’s daily function, it is important to manage symptoms through pain relief and joint protection strategies. Additionally, the presence of hand OA may increase the risk of future hip and knee OA, particularly for hip OA.

The x-ray findings suggest that the patient is suffering from ankylosing spondylitis, a type of seronegative spondyloarthropathy that causes fusion of the spine and sacroiliac joints. The x-ray of the sacroiliac joints shows subchondral sclerosis and erosions, while the x-ray of the spine may reveal a ‘bamboo spine’ appearance and squaring of lumbar vertebrae. Therefore, the correct answer is ‘subchondral sclerosis of the sacroiliac joint’. It is important to note that chondrocalcinosis at the patellofemoral joint is a classic finding in pseudogout, while pencil-in-cup deformity is a classic finding in psoriatic arthropathy and rheumatoid arthritis. Additionally, ‘squaring’ rather than ’rounding’ of the lumbar vertebrae is seen in ankylosing spondylitis on lumbar x-rays, and subchondral sclerosis is a common feature at the patellofemoral joint in osteoarthritis.

Investigating and Managing Ankylosing Spondylitis

Ankylosing spondylitis is a type of spondyloarthropathy that is associated with HLA-B27. It is more commonly seen in males aged 20-30 years old. Inflammatory markers such as ESR and CRP are usually elevated, but normal levels do not necessarily rule out ankylosing spondylitis. HLA-B27 is not a reliable diagnostic tool as it can also be positive in normal individuals. The most effective way to diagnose ankylosing spondylitis is through a plain x-ray of the sacroiliac joints. However, if the x-ray is negative but suspicion for AS remains high, an MRI can be obtained to confirm the diagnosis.

Management of ankylosing spondylitis involves regular exercise, such as swimming, and the use of NSAIDs as the first-line treatment. Physiotherapy can also be helpful. Disease-modifying drugs used for rheumatoid arthritis, such as sulphasalazine, are only useful if there is peripheral joint involvement. Anti-TNF therapy, such as etanercept and adalimumab, should be given to patients with persistently high disease activity despite conventional treatments, according to the 2010 EULAR guidelines. Ongoing research is being conducted to determine whether anti-TNF therapies should be used earlier in the course of the disease. Spirometry may show a restrictive defect due to a combination of pulmonary fibrosis, kyphosis, and ankylosis of the costovertebral joints.

The patient’s symptoms of swelling and pain in the distal interphalangeal joints and dactylitis suggest a diagnosis of psoriatic arthritis. This is further supported by her use of a prescription coal tar shampoo for psoriatic lesions on her scalp. Psoriatic joint disease can cause a distinct X-ray appearance known as a pencil-in-cup deformity, characterized by periarticular erosions and bone resorption.

In contrast, erosions with overhanging edges, also known as rat-bite erosions, are associated with gout and tophi, typically affecting the first metatarsal joint in the foot. Joint effusion may be present in the early stages of septic arthritis, which should be ruled out for any hot, painful swollen joint. However, the patient’s lack of systemic illness and unchanged swelling over time make septic arthritis less likely.

Osteoarthritis, a non-inflammatory degenerative arthritis that worsens with age, does not typically present with dactylitis and is characterized by X-ray features such as loss of joint space, osteophytes, and subchondral sclerosis.

Psoriatic arthropathy is a type of inflammatory arthritis that is associated with psoriasis. It is classified as one of the seronegative spondyloarthropathies and is known to have a poor correlation with cutaneous psoriasis. In fact, it often precedes the development of skin lesions. This condition affects both males and females equally, with around 10-20% of patients with skin lesions developing an arthropathy.

The presentation of psoriatic arthropathy can vary, with different patterns of joint involvement. The most common type is symmetric polyarthritis, which is very similar to rheumatoid arthritis and affects around 30-40% of cases. Asymmetrical oligoarthritis is another type, which typically affects the hands and feet and accounts for 20-30% of cases. Sacroiliitis, DIP joint disease, and arthritis mutilans (severe deformity of fingers/hand) are other patterns of joint involvement. Other signs of psoriatic arthropathy include psoriatic skin lesions, periarticular disease, enthesitis, tenosynovitis, dactylitis, and nail changes.

To diagnose psoriatic arthropathy, X-rays are often used. These can reveal erosive changes and new bone formation, as well as periostitis and a pencil-in-cup appearance. Management of this condition should be done by a rheumatologist, and treatment is similar to that of rheumatoid arthritis. However, there are some differences, such as the use of monoclonal antibodies like ustekinumab and secukinumab. Mild peripheral arthritis or mild axial disease may be treated with NSAIDs alone, rather than all patients being on disease-modifying therapy as with RA. Overall, psoriatic arthropathy has a better prognosis than RA.

Understanding Interferons

Interferons are a type of cytokine that the body produces in response to viral infections and neoplasia. They are categorized based on the type of receptor they bind to and their cellular origin. IFN-alpha and IFN-beta bind to type 1 receptors, while IFN-gamma binds only to type 2 receptors.

IFN-alpha is produced by leucocytes and has antiviral properties. It is commonly used to treat hepatitis B and C, Kaposi’s sarcoma, metastatic renal cell cancer, and hairy cell leukemia. However, it can cause flu-like symptoms and depression as side effects.

IFN-beta is produced by fibroblasts and also has antiviral properties. It is particularly useful in reducing the frequency of exacerbations in patients with relapsing-remitting multiple sclerosis.

IFN-gamma is mainly produced by natural killer cells and T helper cells. It has weaker antiviral properties but plays a significant role in immunomodulation, particularly in macrophage activation. It may be beneficial in treating chronic granulomatous disease and osteopetrosis.

Understanding the different types of interferons and their properties can help in the development of targeted treatments for various diseases.

Isoniazid is the tuberculosis antibiotic that can lead to drug-induced lupus. Drug-induced lupus is a condition that shares some symptoms with systemic lupus erythematosus (SLE), but not all. It usually goes away once the patient stops taking the medication. Anti-histone antibodies are typically positive in drug-induced lupus, but less common in SLE. On the other hand, anti-dsDNA antibodies are present in more than half of SLE cases, but very rarely in drug-induced lupus. Procainamide and hydralazine are the most common drugs that cause drug-induced lupus, but isoniazid is the most likely cause from the list of tuberculosis antibiotics (and pyridoxine). Isoniazid is also known to cause peripheral neuropathy and hepatitis. Ethambutol is another tuberculosis antibiotic that does not cause drug-induced lupus, but can cause optic neuritis. Pyrazinamide is another tuberculosis antibiotic that does not cause drug-induced lupus, but can cause gout and hepatitis. Pyridoxine is vitamin B6 and is given to all patients taking isoniazid to prevent peripheral neuropathy. It does not cause drug-induced lupus.

Understanding Drug-Induced Lupus

Drug-induced lupus is a condition that shares some similarities with systemic lupus erythematosus, but not all of its typical features are present. Unlike SLE, renal and nervous system involvement is rare in drug-induced lupus. The good news is that this condition usually resolves once the drug causing it is discontinued.

The most common symptoms of drug-induced lupus include joint pain, muscle pain, skin rashes (such as the malar rash), and pulmonary issues like pleurisy. In terms of laboratory findings, patients with drug-induced lupus typically test positive for ANA (antinuclear antibodies) but negative for dsDNA (double-stranded DNA) antibodies. Anti-histone antibodies are found in 80-90% of cases, while anti-Ro and anti-Smith antibodies are only present in around 5% of cases.

The most common drugs that can cause drug-induced lupus are procainamide and hydralazine. Other less common culprits include isoniazid, minocycline, and phenytoin.

Before prescribing bisphosphonates for a patient with osteoporosis, it is important to correct any deficiencies in calcium and vitamin D. This is especially crucial for patients with hypocalcemia or vitamin D deficiency, as bisphosphonates can worsen these conditions by reducing calcium efflux from bones. In this case, the patient should receive calcium and vitamin D supplements before starting on alendronic acid. Hormone replacement therapy is not recommended for osteoporosis prevention, and vitamin D and alendronic acid should not be prescribed without also addressing calcium deficiencies.

Bisphosphonates: Uses and Adverse Effects

Bisphosphonates are drugs that mimic the action of pyrophosphate, a molecule that helps prevent bone demineralization. They work by inhibiting osteoclasts, which are cells that break down bone tissue. This reduces the risk of bone fractures and can be used to treat conditions such as osteoporosis, hypercalcemia, Paget’s disease, and pain from bone metastases.

However, bisphosphonates can have adverse effects, including oesophageal reactions such as oesophagitis and ulcers, osteonecrosis of the jaw, and an increased risk of atypical stress fractures of the proximal femoral shaft in patients taking alendronate. Patients may also experience an acute phase response, which can cause fever, myalgia, and arthralgia. Hypocalcemia, or low calcium levels, can also occur due to reduced calcium efflux from bone, but this is usually not clinically significant.

To minimize the risk of adverse effects, patients taking oral bisphosphonates should swallow the tablets whole with plenty of water while sitting or standing. They should take the medication on an empty stomach at least 30 minutes before breakfast or other oral medications and remain upright for at least 30 minutes after taking the tablet. Hypocalcemia and vitamin D deficiency should be corrected before starting bisphosphonate treatment, and calcium supplements should only be prescribed if dietary intake is inadequate. The duration of bisphosphonate treatment varies depending on the patient’s level of risk, and some authorities recommend stopping treatment after five years for low-risk patients with a femoral neck T-score of > -2.5.

To diagnose adult-onset Still’s disease, it is necessary to exclude other conditions by ensuring that rheumatoid factor and anti-nuclear antibody tests are negative. The presence of joint pain, spiking fevers, and a pink bumpy rash is a characteristic triad of symptoms associated with this disease. High serum ferritin and leucocytosis are also commonly observed. Negative results for rheumatoid factor and anti-nuclear antibody tests help to rule out rheumatoid arthritis and systemic lupus erythematosus. Spiking fevers are not typically associated with Wilson’s disease or haemochromatosis. This information is based on the Oxford Handbook of Clinical Specialties (10th Edition), page 654.

Still’s disease in adults is a condition that has a bimodal age distribution, affecting individuals between the ages of 15-25 years and 35-46 years. The disease is characterized by symptoms such as arthralgia, elevated serum ferritin, a salmon-pink maculopapular rash, pyrexia, lymphadenopathy, and a daily pattern of worsening joint symptoms and rash in the late afternoon or early evening. The disease is typically diagnosed using the Yamaguchi criteria, which has a sensitivity of 93.5% and is the most widely used criteria for diagnosis.

Managing Still’s disease in adults can be challenging, and treatment options include NSAIDs as a first-line therapy to manage fever, joint pain, and serositis. It is recommended that NSAIDs be trialed for at least a week before steroids are added. While steroids may control symptoms, they do not improve prognosis. If symptoms persist, the use of methotrexate, IL-1, or anti-TNF therapy can be considered.

Based on the patient’s symptoms, physical examination, and radiological findings, it is likely that they are suffering from a stress fracture in their second metatarsal. The presence of callus indicates that immobilization may not be effective in treating the injury. Freiberg’s disease, which typically affects the head of the second metatarsal during puberty, is characterized by anterior metatarsalgia and is caused by stress microfractures at the growth plate. However, the key factor that distinguishes a stress fracture from Freiberg’s disease is the radiological evidence. In Freiberg’s disease, x-ray changes include joint space widening, bony spur formation, sclerosis, and flattening of the metatarsal head.

Stress fractures are small hairline fractures that can occur due to repetitive activity and loading of normal bone. Although they can be painful, they are typically not displaced and do not cause surrounding soft tissue injury. In some cases, stress fractures may present late, and callus formation may be visible on radiographs. Treatment for stress fractures may vary depending on the severity of the injury. In cases where the injury is associated with severe pain and presents at an earlier stage, immobilization may be necessary. However, injuries that present later may not require formal immobilization and can be treated with tailored immobilization specific to the site of injury.

The most specific test for limited cutaneous systemic sclerosis among patients with systemic sclerosis is the anti-centromere antibodies.

Understanding Systemic Sclerosis

Systemic sclerosis is a condition that affects the skin and other connective tissues, but its cause is unknown. It is more common in females, with three patterns of the disease. Limited cutaneous systemic sclerosis is characterised by Raynaud’s as the first sign, affecting the face and distal limbs, and associated with anti-centromere antibodies. CREST syndrome is a subtype of limited systemic sclerosis that includes Calcinosis, Raynaud’s phenomenon, oEsophageal dysmotility, Sclerodactyly, and Telangiectasia. Diffuse cutaneous systemic sclerosis affects the trunk and proximal limbs, associated with scl-70 antibodies, and has a poor prognosis. Respiratory involvement is the most common cause of death, with interstitial lung disease and pulmonary arterial hypertension being the primary complications. Renal disease and hypertension are also possible complications, and patients with renal disease should be started on an ACE inhibitor. Scleroderma without internal organ involvement is characterised by tightening and fibrosis of the skin, manifesting as plaques or linear. Antibodies such as ANA, RF, anti-scl-70, and anti-centromere are associated with different types of systemic sclerosis.

Ankylosing spondylitis is primarily managed through exercise and NSAIDs. NSAIDs are effective in relieving symptoms and preventing functional limitations, while regular exercise, including postural training, range of motion exercises, stretching, and recreational activities like swimming, can help reduce and prevent functional limitations.

To measure disease activity, the Ankylosing Spondylitis Disease Activity Score (ASDAS) is used, which categorizes disease activity as inactive, low, high, or very high. If a patient has persistently high disease activity despite conventional treatments with NSAIDs, anti-tumor necrosis factor (TNF) therapy may be considered. However, the disease activity must be at least high (≥2.1) on ASDAS to warrant biologic therapy.

Glucocorticoids are not recommended for patients with ankylosing spondylitis. Methotrexate may be prescribed if conventional treatment with NSAIDs does not control symptoms, specifically for persistent peripheral arthritis.

In severe cases where the disease has progressed, surgery may be necessary. Hip and spine surgery may be beneficial for select patients with persistent pain or severe limitation in mobility, neurologic impairment, or severe flexion deformities.

Investigating and Managing Ankylosing Spondylitis

Ankylosing spondylitis is a type of spondyloarthropathy that is associated with HLA-B27. It is more commonly seen in males aged 20-30 years old. Inflammatory markers such as ESR and CRP are usually elevated, but normal levels do not necessarily rule out ankylosing spondylitis. HLA-B27 is not a reliable diagnostic tool as it can also be positive in normal individuals. The most effective way to diagnose ankylosing spondylitis is through a plain x-ray of the sacroiliac joints. However, if the x-ray is negative but suspicion for AS remains high, an MRI can be obtained to confirm the diagnosis.

Management of ankylosing spondylitis involves regular exercise, such as swimming, and the use of NSAIDs as the first-line treatment. Physiotherapy can also be helpful. Disease-modifying drugs used for rheumatoid arthritis, such as sulphasalazine, are only useful if there is peripheral joint involvement. Anti-TNF therapy, such as etanercept and adalimumab, should be given to patients with persistently high disease activity despite conventional treatments, according to the 2010 EULAR guidelines. Ongoing research is being conducted to determine whether anti-TNF therapies should be used earlier in the course of the disease. Spirometry may show a restrictive defect due to a combination of pulmonary fibrosis, kyphosis, and ankylosis of the costovertebral joints.

The diagnosis of chronic kidney disease is incorrect in this case. An eGFR below 90 can still be considered normal if it is above 60 and there are no abnormalities in the U&Es. The patient’s eGFR is 62 and their urea and creatinine levels are within normal range, indicating that they do not have CKD. In cases of CKD, secondary hyperparathyroidism may occur, which would result in different blood test results. Since the kidneys are responsible for activating vitamin D, which is essential for the absorption of calcium in the intestines, low serum calcium levels would be expected in CKD. Additionally, due to kidney dysfunction, there would be inadequate excretion of phosphate, leading to increased serum phosphate levels. This increase in phosphate levels would cause calcium to be deposited in the insoluble calcium phosphate salt, further lowering calcium levels. Therefore, the symptoms of hypercalcemia that the patient is experiencing would not be present in secondary hyperparathyroidism caused by CKD. In summary, hyperparathyroidism secondary to CKD would result in low calcium and high phosphate levels, rather than high calcium and low phosphate levels.

Lab Values for Bone Disorders

When it comes to bone disorders, certain lab values can provide important information for diagnosis and treatment. In cases of osteoporosis, calcium, phosphate, alkaline phosphatase (ALP), and parathyroid hormone (PTH) levels are typically within normal ranges. However, in osteomalacia, there is a decrease in calcium and phosphate levels, an increase in ALP levels, and an increase in PTH levels.

Primary hyperparathyroidism, which can lead to osteitis fibrosa cystica, is characterized by increased calcium and PTH levels, but decreased phosphate levels. Chronic kidney disease can also lead to secondary hyperparathyroidism, with decreased calcium levels and increased phosphate and PTH levels.

Paget’s disease, which causes abnormal bone growth, typically shows normal calcium and phosphate levels, but an increase in ALP levels. Osteopetrosis, a rare genetic disorder that causes bones to become dense and brittle, typically shows normal lab values for calcium, phosphate, ALP, and PTH.

Overall, understanding these lab values can help healthcare professionals diagnose and treat various bone disorders.

Before starting treatment with azathioprine, it is important to check for the presence of thiopurine methyltransferase (TPMT) deficiency, which occurs in approximately 1 in 200 individuals. This deficiency increases the risk of developing pancytopenia related to azathioprine.

Azathioprine is a medication that is broken down into mercaptopurine, which is an active compound that inhibits the production of purine. To determine if someone is at risk for azathioprine toxicity, a test for thiopurine methyltransferase (TPMT) may be necessary. Adverse effects of this medication include bone marrow depression, which can be detected through a full blood count if there are signs of infection or bleeding, as well as nausea, vomiting, pancreatitis, and an increased risk of non-melanoma skin cancer. It is important to note that there is a significant interaction between azathioprine and allopurinol, so lower doses of azathioprine should be used in conjunction with allopurinol. Despite these potential side effects, azathioprine is generally considered safe to use during pregnancy.

Compartment syndrome is characterized by pain when the affected area is passively stretched.

When a patient presents with pain and swelling after recent trauma, compartment syndrome is a likely diagnosis. Pain that worsens over time and is exacerbated by passive stretching are key indicators of this condition. While other symptoms such as pulselessness, pallor, paraesthesia, and paralysis may also be present, they are not necessary for a suspicion of compartment syndrome.

Although compartment syndrome can be diagnosed clinically, measuring compartment pressure is the preferred method for confirming the diagnosis. X-rays are not useful in detecting compartment syndrome and may not show any abnormalities. The ankle-brachial pressure index is used to diagnose critical limb ischemia, not compartment syndrome. Doppler ultrasound can be used to examine the vasculature of the lower leg, but it is not a diagnostic tool for compartment syndrome.

Compartment syndrome is a complication that can occur after fractures or vascular injuries. It is characterized by increased pressure within a closed anatomical space, which can lead to tissue death. Supracondylar fractures and tibial shaft injuries are the most common fractures associated with compartment syndrome. Symptoms include pain, numbness, paleness, and possible paralysis of the affected muscle group. Diagnosis is made by measuring intracompartmental pressure, with pressures over 20 mmHg being abnormal and over 40 mmHg being diagnostic. X-rays typically do not show any pathology. Treatment involves prompt and extensive fasciotomies, with careful attention to decompressing deep muscles in the lower limb. Patients may develop myoglobinuria and require aggressive IV fluids. In severe cases, debridement and amputation may be necessary, as muscle death can occur within 4-6 hours.

Hip fracture surgery aims to enable immediate weight bearing to reduce complications associated with immobility. The BOA recommends unrestricted weight bearing to shorten hospital stays and improve patient compliance. The dynamic hip screw requires weight bearing for proper compression of the fracture site.

Hip fractures are a common occurrence, particularly in elderly women with osteoporosis. The femoral head’s blood supply runs up the neck, making avascular necrosis a potential risk in displaced fractures. Symptoms of a hip fracture include pain and a shortened and externally rotated leg. Patients with non-displaced or incomplete neck of femur fractures may still be able to bear weight. Hip fractures can be classified as intracapsular or extracapsular, with the Garden system being a commonly used classification system. Blood supply disruption is most common in Types III and IV fractures.

Intracapsular hip fractures can be treated with internal fixation or hemiarthroplasty if the patient is unfit. Displaced fractures are recommended for replacement arthroplasty, such as total hip replacement or hemiarthroplasty, according to NICE guidelines. Total hip replacement is preferred over hemiarthroplasty if the patient was able to walk independently outdoors with the use of a stick, is not cognitively impaired, and is medically fit for anesthesia and the procedure. Extracapsular hip fractures can be managed with a dynamic hip screw for stable intertrochanteric fractures or an intramedullary device for reverse oblique, transverse, or subtrochanteric fractures.

Primary hyperparathyroidism is often asymptomatic and can be detected through routine blood tests that show raised calcium, low phosphate, and raised parathyroid hormone levels. This condition is a known risk factor for the development of pseudogout or calcium pyrophosphate dihydrate deposition (CPPD) and chondrocalcinosis. However, there is no evidence to suggest an increased risk of gallstones. On the other hand, hyperparathyroidism can increase the risk of renal stones due to elevated serum and urinary calcium levels. Hypoparathyroidism, not hyperparathyroidism, is associated with ectopic soft tissue calcifications. Prolonged hypocalcaemia can increase the risk of cataracts, while hypercalcaemia can lead to corneal calcification. Primary hyperparathyroidism can also increase the risk of osteoporosis, osteitis fibrosa cystica, and pathological fractures, but it is not associated with osteopetrosis.

Pseudogout, also known as acute calcium pyrophosphate crystal deposition disease, is a type of microcrystal synovitis that occurs when calcium pyrophosphate dihydrate crystals are deposited in the synovium. This condition is more common in older individuals, but those under 60 years of age may develop it if they have underlying risk factors such as haemochromatosis, hyperparathyroidism, low magnesium or phosphate levels, acromegaly, or Wilson’s disease. The knee, wrist, and shoulders are the most commonly affected joints, and joint aspiration may reveal weakly-positively birefringent rhomboid-shaped crystals. X-rays may show chondrocalcinosis, which appears as linear calcifications of the meniscus and articular cartilage in the knee. Treatment involves joint fluid aspiration to rule out septic arthritis, as well as the use of NSAIDs or steroids, as with gout.

The patient’s worsening fever and pain, despite being given antibiotics that were effective against the organism causing the discitis, suggest the presence of an abscess that cannot be reached through the systemic circulation. One possible complication of discitis is an epidural abscess, which is characterized by fever and back pain. While acute pyelonephritis can also cause back pain, it typically radiates from the loin to the groin and may be accompanied by urinary symptoms. Vertebral metastasis is unlikely in this patient without a history of cancer and with the presence of spiking temperatures. Pott’s disease, caused by Mycobacterium tuberculosis, can present with similar symptoms but is not the cause of this patient’s infection, which is caused by Staphylococcus aureus. An epidural hematoma can cause severe back pain, but the absence of fever and no history of trauma make it an unlikely diagnosis.

Understanding Discitis: Causes, Symptoms, Diagnosis, and Treatment

Discitis is a condition characterized by an infection in the intervertebral disc space, which can lead to serious complications such as sepsis or an epidural abscess. The most common cause of discitis is bacterial, with Staphylococcus aureus being the most frequent culprit. However, it can also be caused by viral or aseptic factors. The symptoms of discitis include back pain, pyrexia, rigors, and sepsis. In some cases, neurological features such as changing lower limb neurology may occur if an epidural abscess develops.

To diagnose discitis, imaging tests such as MRI are used due to their high sensitivity. A CT-guided biopsy may also be required to guide antimicrobial treatment. The standard therapy for discitis involves six to eight weeks of intravenous antibiotic therapy. The choice of antibiotic depends on various factors, with the most important being the identification of the organism through a positive culture, such as a blood culture or CT-guided biopsy.

Complications of discitis include sepsis and epidural abscess. Therefore, it is essential to assess the patient for endocarditis, which can be done through transthoracic echo or transesophageal echo. Discitis is usually due to haematogenous seeding of the vertebrae, which implies that the patient has had a bacteraemia, and seeding could have occurred elsewhere. Understanding the causes, symptoms, diagnosis, and treatment of discitis is crucial in managing this condition and preventing its complications.

The most probable diagnosis for a child with a soft, painless swelling behind the knee is a Baker’s cyst. An anterior cruciate ligament tear usually occurs after a twisting injury, is painful, and does not typically present with a lump in the popliteal fossa. A popliteal artery aneurysm would be pulsatile and uncommon in children. A rhabdomyosarcoma is unlikely to be painless and may have other symptoms of systemic disease.

Understanding Baker’s Cysts

Baker’s cysts, also known as popliteal cysts, are not true cysts but rather a distension of the gastrocnemius-semimembranosus bursa. These cysts can be primary or secondary. Primary cysts are not associated with any underlying pathology and are typically seen in children. On the other hand, secondary cysts are associated with an underlying condition such as osteoarthritis and are typically seen in adults.

Baker’s cysts present as swellings in the popliteal fossa, which is located behind the knee. In some cases, the cyst may rupture, resulting in symptoms similar to those of a deep vein thrombosis, such as pain, redness, and swelling in the calf. However, most ruptures are asymptomatic.

In children, Baker’s cysts typically resolve on their own and do not require any treatment. However, in adults, it is important to treat the underlying cause where appropriate. Understanding the nature of Baker’s cysts and their associated symptoms can help individuals seek appropriate medical attention when necessary.

Childhood is the typical time for the manifestation of osteogenesis imperfecta, which is characterized by bone fractures and deformities, blue sclera, and hearing/visual problems.

Osteogenesis imperfecta, also known as brittle bone disease, is a group of disorders that affect collagen metabolism, leading to bone fragility and fractures. The mildest form is type 1, which is the most common. Symptoms include fractures from minor trauma, blue sclera, hearing loss due to otosclerosis, and dental abnormalities.

It is important to consider non-accidental injury as a possible diagnosis. Spiral humeral fractures, digital fractures in non-ambulatory children, and bilateral fractures with varying ages are indicative of this. However, this does not explain the hearing and dental issues.

Osteopetrosis is a condition where bones become denser and harder, and it is most prevalent in young adults. It is an autosomal recessive disorder.

McCune-Albright syndrome is a rare genetic condition that causes abnormal bone development, café au lait spots, premature puberty, and thyroid disorders.

Osteogenesis imperfecta, also known as brittle bone disease, is a group of disorders that affect collagen metabolism, leading to bone fragility and fractures. The most common type of osteogenesis imperfecta is type 1, which is inherited in an autosomal dominant manner and is caused by a decrease in the synthesis of pro-alpha 1 or pro-alpha 2 collagen polypeptides. This condition typically presents in childhood and is characterized by fractures that occur following minor trauma, as well as blue sclera, dental imperfections, and deafness due to otosclerosis.

When investigating osteogenesis imperfecta, it is important to note that adjusted calcium, phosphate, parathyroid hormone, and ALP results are usually normal. This condition can have a significant impact on a person’s quality of life, as it can lead to frequent fractures and other complications. However, with proper management and support, individuals with osteogenesis imperfecta can lead fulfilling lives.

The correct diagnosis for the patient in the vignette is primary hyperparathyroidism. This is indicated by the patient’s symptomatic hypercalcaemia, as well as their blood test results showing a raised calcium, reduced phosphate level, and a raised ALP. Multiple myeloma, Paget’s disease of bone, and sarcoidosis are all incorrect diagnoses as they do not match the patient’s symptoms and blood test results.

Lab Values for Bone Disorders

When it comes to bone disorders, certain lab values can provide important information for diagnosis and treatment. In cases of osteoporosis, calcium, phosphate, alkaline phosphatase (ALP), and parathyroid hormone (PTH) levels are typically within normal ranges. However, in osteomalacia, there is a decrease in calcium and phosphate levels, an increase in ALP levels, and an increase in PTH levels.

Primary hyperparathyroidism, which can lead to osteitis fibrosa cystica, is characterized by increased calcium and PTH levels, but decreased phosphate levels. Chronic kidney disease can also lead to secondary hyperparathyroidism, with decreased calcium levels and increased phosphate and PTH levels.

Paget’s disease, which causes abnormal bone growth, typically shows normal calcium and phosphate levels, but an increase in ALP levels. Osteopetrosis, a rare genetic disorder that causes bones to become dense and brittle, typically shows normal lab values for calcium, phosphate, ALP, and PTH.

Overall, understanding these lab values can help healthcare professionals diagnose and treat various bone disorders.

Chondrocalcinosis is a useful factor in distinguishing between pseudogout and gout. Linear calcifications of the meniscus and articular cartilage seen on a knee x-ray are indicative of pseudogout, but not particularly associated with gout. Therefore, the presence of chondrocalcinosis can be used to differentiate between the two conditions.

Age is not a determining factor in the diagnosis of gout or pseudogout. In this case, the patient’s age of 64 years does not provide any significant information to sway the diagnosis in either direction.

The presence of crystals is not a distinguishing factor between gout and pseudogout, as both conditions involve crystals. However, the type of crystals differs between the two. Pseudogout crystals are weakly-positively birefringent rhomboid-shaped, while gout crystals are negatively birefringent.

Both gout and pseudogout typically respond well to colchicine for acute pain management, so this is not a useful factor in distinguishing between the two conditions.

Increased warmth of the affected joint is not a reliable factor in distinguishing between gout and pseudogout, as it may be present in both conditions.

Pseudogout, also known as acute calcium pyrophosphate crystal deposition disease, is a type of microcrystal synovitis that occurs when calcium pyrophosphate dihydrate crystals are deposited in the synovium. This condition is more common in older individuals, but those under 60 years of age may develop it if they have underlying risk factors such as haemochromatosis, hyperparathyroidism, low magnesium or phosphate levels, acromegaly, or Wilson’s disease. The knee, wrist, and shoulders are the most commonly affected joints, and joint aspiration may reveal weakly-positively birefringent rhomboid-shaped crystals. X-rays may show chondrocalcinosis, which appears as linear calcifications of the meniscus and articular cartilage in the knee. Treatment involves joint fluid aspiration to rule out septic arthritis, as well as the use of NSAIDs or steroids, as with gout.

According to current NICE guidelines, patients with gout who experience two or more attacks per year should receive urate-lowering therapy (ULT). When starting ULT, it is recommended to also prescribe colchicine cover for up to six months. If colchicine is not suitable, NSAID cover may be considered as an alternative. While high-dose prednisolone can effectively treat acute gout, low-dose prednisolone is not appropriate for gout prevention due to the negative effects of long-term corticosteroid use. Given the patient’s history of hiatus hernia, using an NSAID like naproxen or ibuprofen to treat gout may not be the best option. Unlike xanthine oxidase inhibitors such as allopurinol or febuxostat, NSAIDs are not considered ULT and are therefore not recommended for gout prevention.

Gout is caused by chronic hyperuricaemia and is managed acutely with NSAIDs or colchicine. Urate-lowering therapy (ULT) is recommended for patients with >= 2 attacks in 12 months, tophi, renal disease, uric acid renal stones, or prophylaxis if on cytotoxics or diuretics. Allopurinol is first-line ULT, with an initial dose of 100 mg od and titrated to aim for a serum uric acid of < 300 µmol/l. Lifestyle modifications include reducing alcohol intake, losing weight if obese, and avoiding high-purine foods. Consideration should be given to stopping precipitating drugs and losartan may be suitable for patients with coexistent hypertension.

Passive supination of the elbow joint at 90 degrees of flexion is the recommended treatment for subluxation of the radial head, which commonly occurs in young children due to pulling injuries. Pain management and reduction of the radial head into position are the main goals of management. Therefore, option C is the correct answer. Open reduction and internal fixation (option A) and K-wire fixation (option B) are not necessary and too invasive for this condition. Cast immobilization and fracture clinic follow-up (option D) are not indicated as there are no fractures present. An intervention is necessary (option E) due to functional limitation and significant pain.

Subluxation of the Radial Head in Children

Subluxation of the radial head, also known as pulled elbow, is a common upper limb injury in children under the age of 6. This is because the annular ligament covering the radial head has a weaker distal attachment in children at this age group. The signs of this injury include elbow pain and limited supination and extension of the elbow. However, children may refuse examination on the affected elbow due to the pain.

To manage this injury, analgesia is recommended to alleviate the pain. Additionally, passively supinating the elbow joint while the elbow is flexed to 90 degrees can help treat the injury. It is important to seek medical attention if the pain persists or worsens.

The anti-dsDNA test is highly specific for detecting lupus, making it useful in ruling out systemic lupus erythematosus if the results are negative. On the other hand, anti-CCP is utilized in diagnosing rheumatoid arthritis, while anti-La is primarily present in individuals with Sjogren’s syndrome. Although anti-La can also be found in those with lupus, it lacks specificity. Interestingly, infants born to mothers with anti-La and anti-Ro antibodies have an increased risk of developing neonatal lupus. ANCA is an antibody that targets neutrophils and is observed in patients with autoimmune vasculitis.

Systemic lupus erythematosus (SLE) can be investigated through various tests, including antibody tests. ANA testing is highly sensitive, making it useful for ruling out SLE, but it has low specificity. About 99% of SLE patients are ANA positive. Rheumatoid factor testing is positive in 20% of SLE patients. Anti-dsDNA testing is highly specific (>99%), but less sensitive (70%). Anti-Smith testing is also highly specific (>99%), but only 30% of SLE patients test positive. Other antibody tests include anti-U1 RNP, SS-A (anti-Ro), and SS-B (anti-La).

Monitoring of SLE can be done through various markers, including inflammatory markers such as ESR. During active disease, CRP levels may be normal, but a raised CRP may indicate an underlying infection. Complement levels (C3, C4) are low during active disease due to the formation of complexes that lead to the consumption of complement. Anti-dsDNA titres can also be used for disease monitoring, but it is important to note that they are not present in all SLE patients. Proper monitoring of SLE is crucial for effective management of the disease.

Exercise is typically beneficial for inflammatory back pain, such as that seen in ankylosing spondylitis. The patient’s symptoms, including morning stiffness and improvement with exercise, suggest an inflammatory cause, which is supported by the significantly elevated ESR. While there are several possible diagnoses, including seropositive and seronegative spondyloarthropathies, the most likely explanation is ankylosing spondylitis. Psoriatic arthritis is an incorrect answer, as the patient’s rash is more consistent with dermatitis than psoriasis. Osteoarthritis is also unlikely given the patient’s age and clinical history, while reactive arthritis is less likely due to the duration of symptoms and lack of urethritis or conjunctivitis.

Ankylosing spondylitis is a type of spondyloarthropathy that is associated with HLA-B27. It is more commonly seen in young males, with a sex ratio of 3:1, and typically presents with lower back pain and stiffness that develops gradually. The stiffness is usually worse in the morning and improves with exercise, while pain at night may improve upon getting up. Clinical examination may reveal reduced lateral and forward flexion, as well as reduced chest expansion. Other features associated with ankylosing spondylitis include apical fibrosis, anterior uveitis, aortic regurgitation, Achilles tendonitis, AV node block, amyloidosis, cauda equina syndrome, and peripheral arthritis (more common in females).